We are live on ! Find out more
WWC

Waypoint Wealth Counsel Portfolio holdings

AUM $193M
1-Year Est. Return 30.17%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+30.17%
3 Year Est. Return
+79.76%
5 Year Est. Return
10 Year Est. Return
AUM
$273M
AUM Growth
+$19.5M
Cap. Flow
+$9.1M
Cap. Flow %
3.34%
Top 10 Hldgs %
39.04%
Holding
324
New
56
Increased
131
Reduced
86
Closed
39

Top Sells

Rank Stock Value
1
CBOE icon
Cboe Global Markets
CBOE
+$757K
2
MOH icon
Molina Healthcare
MOH
+$655K
3
DASH icon
DoorDash
DASH
+$596K
4
VEEV icon
Veeva Systems
VEEV
+$555K
5
ADBE icon
Adobe
ADBE
+$416K

Sector Composition

Rank Sector Weight
1 Technology 16.67%
2 Financials 7.71%
3 Consumer Discretionary 6.74%
4 Healthcare 6.21%
5 Consumer Staples 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTR icon
151
Ventas
VTR
$48B
$370K 0.14%
4,784
+734
+18% +$55.4K
CMI icon
152
Cummins
CMI
$87.5B
$369K 0.14%
722
+40
+6% +$18.7K
EME icon
153
Emcor
EME
$35.2B
$367K 0.13%
600
+49
+9% +$31.7K
IXUS icon
154
iShares Core MSCI Total International Stock ETF
IXUS
$58.3B
$365K 0.13%
4,314
TOL icon
155
Toll Brothers
TOL
$13.6B
$363K 0.13%
2,685
-406
-13% -$55.1K
CFG icon
156
Citizens Financial Group
CFG
$30.3B
$363K 0.13%
6,207
+763
+14% +$41K
ALNY icon
157
Alnylam Pharmaceuticals
ALNY
$27.5B
$356K 0.13%
895
+274
+44% +$121K
VOE icon
158
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$356K 0.13%
2,005
ARMK icon
159
Aramark
ARMK
$15B
$353K 0.13%
+9,565
New +$365K
PFE icon
160
Pfizer
PFE
$143B
$351K 0.13%
14,101
-627
-4% -$15.8K
EXEL icon
161
Exelixis
EXEL
$13.3B
$350K 0.13%
+7,991
New +$331K
TGT icon
162
Target
TGT
$65.6B
$350K 0.13%
+3,576
New +$330K
CMG icon
163
Chipotle Mexican Grill
CMG
$47.2B
$349K 0.13%
+9,443
New +$342K
CVX icon
164
Chevron
CVX
$392B
$348K 0.13%
2,284
-330
-13% -$50.3K
INVH icon
165
Invitation Homes
INVH
$17.7B
$347K 0.13%
+12,494
New +$349K
NTNX icon
166
Nutanix
NTNX
$16B
$347K 0.13%
6,714
+3,703
+123% +$226K
COF icon
167
Capital One
COF
$128B
$345K 0.13%
1,425
+367
+35% +$81.7K
MRSH
168
Marsh
MRSH
$90.5B
$344K 0.13%
+1,853
New +$346K
ORLY icon
169
O'Reilly Automotive
ORLY
$72.9B
$342K 0.13%
3,755
+36
+1% +$3.52K
UTHR icon
170
United Therapeutics
UTHR
$25.8B
$342K 0.13%
+701
New +$326K
FNF icon
171
Fidelity National Financial
FNF
$13.9B
$337K 0.12%
6,169
+1,470
+31% +$83.7K
CCK icon
172
Crown Holdings
CCK
$12.8B
$335K 0.12%
3,255
-699
-18% -$68.1K
ROST icon
173
Ross Stores
ROST
$80.5B
$333K 0.12%
1,849
+113
+7% +$18.9K
FRT icon
174
Federal Realty Investment Trust
FRT
$10.7B
$331K 0.12%
3,284
+977
+42% +$96.2K
CIEN icon
175
Ciena
CIEN
$53.4B
$327K 0.12%
+1,399
New +$271K

Similar funds

Waypoint Wealth Counsel's Q4 2025 Portfolio in Review

As of Q4 2025, Waypoint Wealth Counsel held 324 positions worth $273M, up 7.7% from $253M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Waypoint Wealth Counsel deployed $9.1M of net new capital in Q4 2025, opening 56 new positions and adding to 131 existing holdings. Its largest new stake was Bristol-Myers Squibb: 22,134 shares worth $1.19M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Cboe Global Markets, an estimated $757K trimmed.

  • Waypoint Wealth Counsel's largest Q4 2025 buy was Bristol-Myers Squibb: 22,134 shares worth $1.19M.
  • Waypoint Wealth Counsel added most to Vanguard High Dividend Yield ETF in Q4 2025, an estimated $656K increase.
  • Waypoint Wealth Counsel's biggest Q4 2025 reduction was Cboe Global Markets, cutting an estimated $757K.
  • Waypoint Wealth Counsel fully exited Molina Healthcare in Q4 2025, selling an estimated $655K.
  • Waypoint Wealth Counsel's ten largest holdings make up 39% of its $273M portfolio in Q4 2025.
  • Waypoint Wealth Counsel opened 56 new positions and closed 39 in Q4 2025.
  • Waypoint Wealth Counsel's portfolio value rose 7.7% quarter-over-quarter to $273M.

Based on Waypoint Wealth Counsel's 13F filing for Q4 2025, filed 28 Jan 2026.